Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombolysis in patients with diabetes.

× No keyword cloud information.

7 in total

1. Retinal haemorrhage after thrombolytic therapy.

Authors: B Caramelli; B Tranchesi; O C Gebara; L C de Sa; F J Pileggi
Journal: Lancet Date: 1991-06-01 Impact factor: 79.321

2. Intraocular hemorrhage associated with intravenously administered streptokinase.

Authors: P Sunderraj
Journal: Am J Ophthalmol Date: 1991-12-15 Impact factor: 5.258

3. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators.

Authors: M A Pfeffer; L A Moyé; E Braunwald; L Basta; E J Brown; T E Cuddy; G R Dagenais; G O Flaker; E M Geltman; B J Gersh
Journal: JAMA Date: 1991 Jul 24-31 Impact factor: 56.272

4. Factors that influence outcome in diabetic subjects with myocardial infarction.

Authors: S Fava; J Azzopardi; H A Muscat; F F Fenech
Journal: Diabetes Care Date: 1993-12 Impact factor: 19.112

5. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Authors: G I Barbash; H D White; M Modan; F Van de Werf
Journal: J Am Coll Cardiol Date: 1993-09 Impact factor: 24.094

6. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase.

Authors: A S Lew; H Hod; B Cercek; P K Shah; W Ganz
Journal: Am J Cardiol Date: 1987-01-01 Impact factor: 2.778

7. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Authors: C B Granger; R M Califf; S Young; R Candela; J Samaha; S Worley; D J Kereiakes; E J Topol
Journal: J Am Coll Cardiol Date: 1993-03-15 Impact factor: 24.094

7 in total

5 in total

Thrombolysis in patients with diabetes.

1. Retinal haemorrhage after thrombolytic therapy.

2. Intraocular hemorrhage associated with intravenously administered streptokinase.

3. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators.

4. Factors that influence outcome in diabetic subjects with myocardial infarction.

5. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

6. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase.

7. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

1. The St Vincent Task Force for diabetes: report of the cardiovascular disease subgroup.

2. Thrombolysis in patients with diabetes. More evidence that the treatment should not necessarily be withheld.

3. Thrombolysis in patients with diabetes. Risk of intraocular haemorrhage remains unknown.

4. Thrombolysis in patients with diabetes. Prophylaxis with aspirin should be considered.

5. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.